BSE filing, NSE: DOLPHMED. Summary written from the filing by ALFA Finder's alert engine.
Dolphin Medical Services Ltd: key numbers
- Share price
- ₹6.78
- Market cap
- ₹10.24 Cr
- Revenue (annual)
- ₹0.75 Cr
- Net profit (annual)
- ₹0.04 Cr
- P/E (TTM)
- 214.6×Sector 52.0×
- Promoter holding
- 100.00%+73.56% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dolphin Medical Services Ltd
All →Dolphin Medical Services Other Announcement
Dolphin Medical Services Ltd filed its quarterly shareholding pattern as mandated by SEBI Regulation 31(1)(b). This document provides no material business event.
Dolphin Medical Services Management Change
Dolphin Medical Services appointed Mr. Kotha as Chairman and Promoter Director, reclassifying Mr. Mallour to Promoter Director. The board also reconstituted its committees.
Dolphin Medical Services Board Meeting Date
Dolphin Medical Services scheduled a board meeting for September 21, 2026. The agenda includes board appointments, committee reconstitution, and promoter reclassification.
Dolphin Medical Services Annual General Meeting
Dolphin Medical Services Ltd received Registrar of Companies approval to extend its Annual General Meeting deadline by two months. The meeting is now scheduled for November 30, 2026.
- Execution
- 2 months extension
Dolphin Medical Services Open Offer: ₹0.01 Cr
Acquirers Amarandhar Reddy Kotha and Mallour Rajesh Kumar completed an open offer for Dolphin Medical Services Limited. They acquired 18,000 shares at ₹4.80 each, totaling ₹0.01 Crore.
- Value
- ₹0.01 Cr
Dolphin Medical Services Q1 FY27 Results: Net Profit ₹0 Cr
Dolphin Medical Services Ltd reported revenue from operations of ₹0.2 Cr (+0.0% YoY) and net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.